Inside Innovation

Seattle-based CounterX Therapeutics has secured exclusive licensing agreements with the University of Washington and the University of Minnesota to develop treatments aimed at preventing opioid

A team from the University of Washington won the 2026 Hollomon Health Innovation Challenge with CPRight, a device designed to provide real-time feedback that improves

Washington has a problem. We have too many good jobs. Why is that a problem? Not enough of them are going to Washingtonians. As leaders

Seattle’s life sciences ecosystem stands out for companies applying artificial intelligence to accelerate drug discovery, diagnostics and therapeutic development. Greater Seattle ranks among the top

A 15-year follow-up analysis led by researchers at Fred Hutch Cancer Center suggests that follicular lymphoma may be curable for some patients treated with chemoimmunotherapy.

Researchers from Weill Cornell Medicine and the Allen Institute have discovered that pain-sensing neurons in the gut help coordinate the immune system’s response to intestinal

Fred Hutch Cancer Center scientists have developed genetically human monoclonal antibodies that block Epstein-Barr virus from infecting human immune cells, marking a key milestone in

The Allen Institute has partnered with Anthropic to design and deploy custom autonomous AI agents that will accelerate bioscience research and help unlock new approaches

Seattle-based startup mpathic is expanding to help foundational model developers and LLM-powered application teams reduce dangerous responses and better protect vulnerable users. Founded in 2021

Lundbeck’s intravenous monoclonal antibody significantly reduced the number of monthly migraine days compared to placebo in a phase 2b study after the company had previously

AGC Biologics’ Seattle manufacturing facility has received Good Manufacturing Practices (GMP) certification from Brazil’s health regulatory authority, Agência Nacional de Vigilância Sanitária, enabling biologics and

A new vaccine designed to protect against multiple coronaviruses, including COVID-19, has entered human clinical testing after being developed using technology from the University of